The New Zealand government confirmed yesterday the partial sell-off of national flag carrier Air New Zealand to local and offshore institutions.
It did not say how much it expected to raise from the long-expected sale, but market analysts have previously forecast about NZ$400 million (US$330 million).
The government will reduce its holding from 73 percent to 53 percent in the sale, which will commence today, New Zealand Minister of Finance Bill English said.
“We expect the transaction to be completed by Tuesday evening,” English added, without saying who might buy the shares.
Craigs Investment Partners, Deutsche Bank and Goldman Sachs have been appointed to undertake the transaction and work with New Zealand stockbrokers.
Air New Zealand, which is listed on both the New Zealand and Australian stock exchanges (NZX and ASX), has been trading in recent weeks around a five-year high and closed in New Zealand on Friday at NZ$1.65.
The airline said it would request a trading halt on the two exchanges while the sale process was carried out.
“Shareholding sell-downs of this type are typically conducted off-market when the company’s shares are not trading on a stock exchange, to ensure the company’s share price is not affected by speculative trading,” English said.
“We expect Air New Zealand’s shares to resume trading on the NZX and ASX on Wednesday,” he added.
The sale is being carried out just days ahead of a national referendum on the sale of government assets, which has so far seen the disposal of 49 percent of electricity generating companies Mighty River Power and Meridian Energy.
New Zealand Minister for State Owned Enterprises Tony Ryall said the first two share offers had raised NZ$3.6 billion.
“The proceeds of the program have been allocated to the Future Investment Fund, so the money can be reinvested in new assets and new infrastructure without the need to borrow money from overseas lenders,” he said.
Air New Zealand issued a statement saying it considered the sale “a matter solely for the government” and would not comment further.
This time was supposed to be different. The memorychip sector, famous for its boom-and-bust cycles, had changed its ways. A combination of more disciplined management and new markets for its products — including 5G technology and cloud services — would ensure that companies delivered more predictable earnings. Yet, less than a year after memory companies made such pronouncements, the US$160 billion industry is suffering one of its worst routs ever. There is a glut of the chips sitting in warehouses, customers are cutting orders and product prices have plunged. “The chip industry thought that suppliers were going to have better control,” said
Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday. After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures. “It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent
Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors — COVID-19 misinformation has bred a so-called “pure blood” movement. The movement spins anti-vaccine narratives focused on unfounded claims that receiving blood from people inoculated against COVID-19 “contaminates” the body. Some have advocated for blood banks that draw from “pure” unvaccinated people, while medics in North America say they have fielded requests from people demanding transfusions from donors who have not received a vaccine. In closed social media groups, vaccine skeptics — who brand themselves as “pure bloods” — promote violence against doctors
Asteroid mining start-up AstroForge Inc is planning to launch its first two missions to space this year as it seeks to extract and refine metals from deep space. The first launch, scheduled for April, is to test AstroForge’s technique for refining platinum from a sample of asteroid-like material. The second, planned for October, would scout for an asteroid near Earth to mine. The missions are part of AstroForge’s goal of refining platinum-group metals from asteroids, with the aim of bringing down the cost of mining these metals. It also hopes to reduce the massive amount of carbon emissions that stem from mining
RSS